There is hardly any other sector that faces such complex requirements regarding product information and labelling as the pharmaceutical industry.
Unlike serialisation, the requirements of which are described in great detail in EU Directive 2016/161, the information in relation to the issue of anti-manipulation are very vague. It leaves many questions unanswered.
With that in mind, a team of HERMA experts has prepared a detailed white paper that provides you with all of the relevant information about sealing and tamper-proof folding carton packaging in the pharmaceuticals sector.
Read more about the requirements placed on pharmaceutical companies by the Falsified Medicines Directive 2011/62/EU, the possible options in relation to anti-manipulation and the benefits of sealing labels.
Email firstname.lastname@example.org today for your free copy and make sure that your company can introduce the steps required in good time.